Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Compound Preferred LLC
WARNING LETTER
•Compound Preferred LLC•March 1, 2017

Compound Preferred LLC – FDA Warning Letter, Mar 1, 2017

Record Details

On October 27, 2017, the FDA issued a Warning Letter to RAM Pharma, Inc., an outsourcing facility registered under section 503B of the FDCA. An inspection from February 7 to March 1, 2017, revealed serious deficiencies in sterile drug production and failure to meet 503B conditions, rendering products adulterated and misbranded.

Violations included: - **Failure to meet 503B conditions:** Drug labels lacked required statements (e.g., "This is a compounded drug," quantity/volume, adverse event reporting info, ingredient lists). The facility also failed to submit initial and complete drug product reports in July and December 2016. - **Adulterated Drug Products (Insanitary Conditions):** The ISO-5 hood was constructed of unfinished particle board, 19 lots of sterile products were released from an uncertified ISO-5 hood, an industrial vacuum was used in the ISO-7 clean room before production, media fills were not conducted, and non-sterile wipes were used in the ISO-5 hood. - **Adulterated Drug Products (CGMP Violations):** Failures included maintaining aseptic equipment, establishing procedures to prevent microbiological contamination, cleaning/disinfecting rooms/equipment, testing for final specifications (sterility/endotoxins), ensuring appropriate personnel gowning, and establishing stability testing programs. - **Misbranded Drug

Company
Compound Preferred LLC
Inspection date
March 1, 2017
Product type
Drugs
Office
Los Angeles District Office
Person
  • Steven E. Porter (Program Division Director)
View Company Profile

ID · d7d4a707-3d72-4915-bda4-bc79715216e7

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 U.S.C. 353b21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 U.S.C. 360eee-121 U.S.C. 351(a)(2)(A)21 U.S.C. 353b(a)(10)21 U.S.C. 353b(b)(2)21 U.S.C. 331(k)21 U.S.C. 331(ccc)(3)

Full citation text and observation details available on the Dashboard.

Other documents for Compound Preferred LLC
  • 483 - 2021-12-17December 17, 2021
  • 483 - 2019-08-01August 1, 2019
  • 483 - 2017-03-01March 1, 2017
  • 483_RESPONSE - 2017-03-01March 1, 2017

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Compound Preferred LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.